When the medicine isn't enough: Why GLP-1s need a digital lifeline

Matthias Winker

6/20/20251 min read

a sign on a beach
a sign on a beach

Last weekend, my mum told me about a family friend whoโ€™d finally started one of the new GLPโ€‘1 medications. She had every clinical indication. She hoped the injection would help her lose the weight she had battled with for years.

So when my mum asked if sheโ€™d lost any weight, the disappointing answer was โ€œ๐˜•๐˜ฐ, ๐˜ฏ๐˜ฐ๐˜ต ๐˜ณ๐˜ฆ๐˜ข๐˜ญ๐˜ญ๐˜บ.โ€ My mum asked: โ€œ๐˜‹๐˜ช๐˜ฅ ๐˜บ๐˜ฐ๐˜ถ ๐˜ฅ๐˜ฐ ๐˜ข๐˜ฏ๐˜บ๐˜ต๐˜ฉ๐˜ช๐˜ฏ๐˜จ ๐˜ฆ๐˜ญ๐˜ด๐˜ฆ? ๐˜”๐˜ฐ๐˜ณ๐˜ฆ ๐˜ฎ๐˜ฐ๐˜ท๐˜ฆ๐˜ฎ๐˜ฆ๐˜ฏ๐˜ต? ๐˜š๐˜ฎ๐˜ข๐˜ญ๐˜ญ๐˜ฆ๐˜ณ ๐˜ฑ๐˜ฐ๐˜ณ๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ด? ๐˜š๐˜ฐ๐˜ฎ๐˜ฆ ๐˜ฌ๐˜ช๐˜ฏ๐˜ฅ ๐˜ฐ๐˜ง ๐˜ด๐˜ถ๐˜ฑ๐˜ฑ๐˜ฐ๐˜ณ๐˜ต?โ€ Again, a "๐˜•๐˜ฐ."

No change. No digital companion. No coaching. No tracking. Just the jab, and hope. This got me thinking and found that:

๐—ฆ๐—ต๐—ฒโ€™๐˜€ ๐—ป๐—ผ๐˜ ๐—ฎ๐—น๐—ผ๐—ป๐—ฒ

  • In the UK, digital platforms supporting GLPโ€‘1 use led to significantly improved weight loss outcomes.

  • In Australia, patients using digital tools stayed on the medication for a median of 115 days, about 4 months.

  • Contrast that with the U.S., where only 1 in 4 patients still take Wegovy or Ozempic after two years.

Thatโ€™s not a failure of the drug. Thatโ€™s a failure of follow-through.

๐—ช๐—ต๐—ฎ๐˜ ๐—ฐ๐—ผ๐˜‚๐—น๐—ฑ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—ต๐—ฒ๐—น๐—ฝ๐—ฒ๐—ฑ ๐—ต๐—ฒ๐—ฟ ๐˜๐—ผ ๐˜€๐˜‚๐—ฐ๐—ฐ๐—ฒ๐—ฒ๐—ฑ?

  • Remote onboarding and education to start patients off right.

  • Daily logs and nudges to keep the habit alive.

  • Quick check-ins with clinicians by video or phone, every few weeks.

  • Smart inventory monitoring, to avoid the โ€œsorry, weโ€™re outโ€ message at the pharmacy.

This isnโ€™t futuristic. We have the tech readily available and itโ€™s happening now. Itโ€™s scalable and when done right, it works.

What isnโ€™t working is the wait-and-see approach. Hoping a GLPโ€‘1 can carry the load alone without support, without infrastructure, without accountability, isnโ€™t strategy. Itโ€™s risk, wasted investments, frustrated patients, and avoidable system strain.

There's no doubt that GLPโ€‘1s are redefining the medical treatment of obesity. But to redefine care, they must be paired with digital ecosystems that are just as thoughtfully designed.

๐—ช๐—ต๐—ฎ๐˜ ๐˜„๐—ผ๐˜‚๐—น๐—ฑ ๐—œ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐˜๐—ผ๐—น๐—ฑ ๐—บ๐˜† ๐—ณ๐—ฎ๐—บ๐—ถ๐—น๐˜† ๐—ณ๐—ฟ๐—ถ๐—ฒ๐—ป๐—ฑ ๐—ถ๐—ณ ๐—œโ€™๐—ฑ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐˜๐—ต๐—ฒ๐—ฟ๐—ฒ?

I wouldโ€™ve said: ๐˜›๐˜ฉ๐˜ฆ ๐˜ฎ๐˜ฆ๐˜ฅ๐˜ช๐˜ค๐˜ช๐˜ฏ๐˜ฆ ๐˜ฉ๐˜ฆ๐˜ญ๐˜ฑ๐˜ด, ๐˜ฃ๐˜ถ๐˜ต ๐˜บ๐˜ฐ๐˜ถ ๐˜ฏ๐˜ฆ๐˜ฆ๐˜ฅ ๐˜ฎ๐˜ฐ๐˜ณ๐˜ฆ ๐˜ต๐˜ฉ๐˜ข๐˜ฏ ๐˜ต๐˜ฉ๐˜ฆ ๐˜ฏ๐˜ฆ๐˜ฆ๐˜ฅ๐˜ญ๐˜ฆ. ๐˜ ๐˜ฐ๐˜ถ ๐˜ฏ๐˜ฆ๐˜ฆ๐˜ฅ ๐˜ข ๐˜ฑ๐˜ญ๐˜ข๐˜ฏ. ๐˜ˆ ๐˜ฑ๐˜ข๐˜ณ๐˜ต๐˜ฏ๐˜ฆ๐˜ณ. ๐˜ˆ ๐˜ด๐˜บ๐˜ด๐˜ต๐˜ฆ๐˜ฎ ๐˜ข๐˜ณ๐˜ฐ๐˜ถ๐˜ฏ๐˜ฅ ๐˜บ๐˜ฐ๐˜ถ.

๐—”๐—ป๐—ฑ ๐˜๐—ต๐—ฎ๐˜โ€™๐˜€ ๐˜„๐—ต๐—ฎ๐˜ ๐˜„๐—ฒ ๐—ป๐—ฒ๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ฏ๐˜‚๐—ถ๐—น๐—ฑ.